Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Diabetologia ; 54(9): 2337-46, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21547497

ABSTRACT

AIMS/HYPOTHESIS: Pro-atherogenic and pro-oxidant, oxidised LDL trigger adverse effects on pancreatic beta cells, possibly contributing to diabetes progression. Because oxidised LDL diminish the expression of genes regulated by the inducible cAMP early repressor (ICER), we investigated the involvement of this transcription factor and of oxidative stress in beta cell failure elicited by oxidised LDL. METHODS: Isolated human and rat islets, and insulin-secreting cells were cultured with human native or oxidised LDL or with hydrogen peroxide. The expression of genes was determined by quantitative real-time PCR and western blotting. Insulin secretion was monitored by EIA kit. Cell apoptosis was determined by scoring cells displaying pycnotic nuclei. RESULTS: Exposure of beta cell lines and islets to oxidised LDL, but not to native LDL raised the abundance of ICER. Induction of this repressor by the modified LDL compromised the expression of important beta cell genes, including insulin and anti-apoptotic islet brain 1, as well as of genes coding for key components of the secretory machinery. This led to hampering of insulin production and secretion, and of cell survival. Silencing of this transcription factor by RNA interference restored the expression of its target genes and alleviated beta cell dysfunction and death triggered by oxidised LDL. Induction of ICER was stimulated by oxidative stress, whereas antioxidant treatment with N-acetylcysteine or HDL prevented the rise of ICER elicited by oxidised LDL and restored beta cell functions. CONCLUSIONS/INTERPRETATION: Induction of ICER links oxidative stress to beta cell failure caused by oxidised LDL and can be effectively abrogated by antioxidant treatment.


Subject(s)
Cyclic AMP Response Element Modulator/physiology , Insulin-Secreting Cells/physiology , Islets of Langerhans/physiopathology , Oxidative Stress/physiology , Acetylcysteine/pharmacology , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Cells, Cultured , Cyclic AMP Response Element Modulator/drug effects , Cyclic AMP Response Element Modulator/genetics , Humans , Hydrogen Peroxide/pharmacology , Insulin/metabolism , Insulin-Secreting Cells/cytology , Insulin-Secreting Cells/drug effects , Islets of Langerhans/cytology , Islets of Langerhans/drug effects , Lipoproteins, LDL/pharmacology , Male , Models, Animal , Oxidative Stress/drug effects , RNA, Small Interfering/pharmacology , Rats , Rats, Sprague-Dawley
2.
Diabetologia ; 50(6): 1304-14, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17437081

ABSTRACT

AIMS/HYPOTHESIS: We explored the potential adverse effects of pro-atherogenic oxidised LDL-cholesterol particles on beta cell function. MATERIALS AND METHODS: Isolated human and rat islets and different insulin-secreting cell lines were incubated with human oxidised LDL with or without HDL particles. The insulin level was monitored by ELISA, real-time PCR and a rat insulin promoter construct linked to luciferase gene reporter. Cell apoptosis was determined by scoring cells displaying pycnotic nuclei. RESULTS: Prolonged incubation with human oxidised LDL particles led to a reduction in preproinsulin expression levels, whereas the insulin level was preserved in the presence of native LDL-cholesterol. The loss of insulin production occurred at the transcriptional levels and was associated with an increase in activator protein-1 transcriptional activity. The rise in activator protein-1 activity resulted from activation of c-Jun N-terminal kinases (JNK, now known as mitogen-activated protein kinase 8 [MAPK8]) due to a subsequent decrease in islet-brain 1 (IB1; now known as MAPK8 interacting protein 1) levels. Consistent with the pro-apoptotic role of the JNK pathway, oxidised LDL also induced a twofold increase in the rate of beta cell apoptosis. Treatment of the cells with JNK inhibitor peptides or HDL countered the effects mediated by oxidised LDL. CONCLUSIONS/INTERPRETATION: These data provide strong evidence that oxidised LDL particles exert deleterious effects in the progression of beta cell failure in diabetes and that these effects can be countered by HDL particles.


Subject(s)
Insulin-Secreting Cells/enzymology , Insulin/genetics , Lipoproteins, HDL/pharmacology , Lipoproteins, LDL/pharmacology , MAP Kinase Kinase 4/metabolism , Animals , Apoptosis , Cell Line , Diabetes Mellitus/enzymology , Disease Progression , Enzyme Activation , Genes, Reporter , Humans , Insulin/metabolism , Insulin Secretion , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/pathology , MAP Kinase Kinase 4/antagonists & inhibitors , Male , Polymerase Chain Reaction , Promoter Regions, Genetic , RNA/genetics , RNA/isolation & purification , Rats , Rats, Sprague-Dawley
3.
Mol Cell Biol ; 21(21): 7256-67, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11585908

ABSTRACT

Islet-brain 1 (IB1) is the human and rat homologue of JIP-1, a scaffold protein interacting with the c-Jun amino-terminal kinase (JNK). IB1 expression is mostly restricted to the endocrine pancreas and to the central nervous system. Herein, we explored the transcriptional mechanism responsible for this preferential islet and neuronal expression of IB1. A 731-bp fragment of the 5' regulatory region of the human MAPK8IP1 gene was isolated from a human BAC library and cloned upstream of a luciferase reporter gene. This construct drove high transcriptional activity in both insulin-secreting and neuron-like cells but not in unrelated cell lines. Sequence analysis of this promoter region revealed the presence of a neuron-restrictive silencer element (NRSE) known to bind repressor zinc finger protein REST. This factor is not expressed in insulin-secreting and neuron-like cells. By mobility shift assay, we confirmed that REST binds to the NRSE present in the IB1 promoter. Once transiently transfected in beta-cell lines, the expression vector encoding REST repressed IB1 transcriptional activity. The introduction of a mutated NRSE in the 5' regulating region of the IB1 gene abolished the repression activity driven by REST in insulin-secreting beta cells and relieved the low transcriptional activity of IB1 observed in unrelated cells. Moreover, transfection in non-beta and nonneuronal cell lines of an expression vector encoding REST lacking its transcriptional repression domain relieved IB1 promoter activity. Last, the REST-mediated repression of IB1 could be abolished by trichostatin A, indicating that deacetylase activity is required to allow REST repression. Taken together, these data establish a critical role for REST in the control of the tissue-specific expression of the human IB1 gene.


Subject(s)
Adaptor Proteins, Signal Transducing , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Gene Expression Regulation, Enzymologic , Repressor Proteins/metabolism , Repressor Proteins/physiology , Transcription Factors/metabolism , Transcription Factors/physiology , 3T3 Cells , Animals , Base Sequence , Blotting, Northern , Carrier Proteins/metabolism , DNA, Complementary/metabolism , Enzyme Inhibitors/pharmacology , Gene Library , HeLa Cells , Humans , Hydroxamic Acids/pharmacology , Mice , Molecular Sequence Data , Mutation , Neurons/metabolism , PC12 Cells , Polymerase Chain Reaction , Promoter Regions, Genetic , RNA, Messenger/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic , Transcriptional Activation , Transfection , Tumor Cells, Cultured , Zinc Fingers
4.
Mol Cell ; 6(5): 1155-67, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11106754

ABSTRACT

Rho-type GTPases control many cytoskeletal rearrangements, but their regulation remains poorly understood. Here, we show that in S. cerevisiae, activation of the CDK Cdc28-Cln2 at bud emergence triggers relocalization of Cdc24, the GEF for Cdc42, from the nucleus to the polarization site, where it is stably maintained by binding to the adaptor Bem1. Locally activated Cdc42 then polarizes the cytoskeleton in a manner dependent on its effectors Bni1 and the PAK-like kinase Cla4. In addition, Cla4 induces phosphorylation of Cdc24, leading to its dissociation from Bem1 at bud tips, thereby ending polarized bud growth in vivo. Our results thus suggest a dynamic temporal and spatial regulation of the Cdc42 module: Cdc28-Cln triggers actin polarization by activating Cdc42, which in turn restricts its own activation via a negative feedback loop acting on its GEF Cdc24.


Subject(s)
Cell Cycle Proteins/metabolism , Cell Polarity , Guanine Nucleotide Exchange Factors , Microfilament Proteins , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , cdc42 GTP-Binding Protein/metabolism , Actins/metabolism , Adaptor Proteins, Signal Transducing , CDC28 Protein Kinase, S cerevisiae/metabolism , Carrier Proteins/metabolism , Cell Cycle Proteins/antagonists & inhibitors , Cell Cycle Proteins/chemistry , Cell Division , Cell Nucleus/metabolism , Cyclins/metabolism , Cytoplasmic Structures/chemistry , Cytoplasmic Structures/metabolism , Cytoskeleton/chemistry , Cytoskeleton/metabolism , Enzyme Activation , Feedback, Physiological , Fungal Proteins/genetics , Fungal Proteins/metabolism , G1 Phase , Guanosine Triphosphate/metabolism , Macromolecular Substances , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/genetics , Protein Transport , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...